Food and beverages for treating metabolic osteopathy
    3.
    发明公开
    Food and beverages for treating metabolic osteopathy 审中-公开
    食品和饮料代谢骨病的治疗

    公开(公告)号:EP2463376A3

    公开(公告)日:2013-01-30

    申请号:EP12001430.3

    申请日:2004-09-30

    申请人: MEIJI CO, LTD.

    摘要: Food and beverages for preventing and treating metabolic ostheopathy, comprising a composition comprising 1,4-dihydroxy-2-naphthoic acid obtained by
    (i) a process for producing 1,4-dihydroxy-2-naphtoic acid comprising initiating the culture of 1,4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions and culturing the bacteria under aeration into the medium when the concentration of a carbon source in the medium is 3.5% by mass or less, or
    (ii) a process for producing 1,4-dihydroxy-2-naphtoic acid, comprising culturing 1,4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions, adding a carbon source to the obtained culture and preserving the culture at 3 to 20 °C under weak alkaline conditions, or
    (iii) a process for producing 1,4-dihydroxy-2-naphtoic acid, comprising initiating the culture of 1, 4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions, culturing the bacteria under aeration into a medium when the concentration of a carbon source in the medium is 3.5% by mass or less, adding the carbon source to the obtained culture and preserving the culture at 3 to 20 °C under weak alkaline conditions,

    as an active ingredient.

    Food and beverages for treating abdominal discomfort
    4.
    发明公开
    Food and beverages for treating abdominal discomfort 审中-公开
    Lebensmittel oderGetränkzur Behandlung von abdominalen Schmerzen

    公开(公告)号:EP2463375A2

    公开(公告)日:2012-06-13

    申请号:EP12001429.5

    申请日:2004-09-30

    申请人: Meiji Co., Ltd.

    摘要: Food and beverages for improving abdominal discomfort, comprising a composition comprising 1,4-dihydroxy-2-naphthoic acid obtained by
    (i) a process for producing 1,4-dihydroxy-2-naphtoic acid comprising initiating the culture of 1,4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions and culturing the bacteria under aeration into the medium when the concentration of a carbon source in the medium is 3.5% by mass or less, or
    (ii) a process for producing 1,4-dihydroxy-2-naphtoic acid, comprising culturing 1,4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions, adding a carbon source to the obtained culture and preserving the culture at 3 to 20 °C under weak alkaline conditions, or
    (iii) a process for producing 1,4-dihydroxy-2-naphtoic acid, comprising initiating the culture of 1, 4-dihydroxy-2-naphthoic acid producing bacteria belonging to propionic acid bacteria under anaerobic conditions, culturing the bacteria under aeration into a medium when the concentration of a carbon source in the medium is 3.5% by mass or less, adding the carbon source to the obtained culture and preserving the culture at 3 to 20 °C under weak alkaline conditions, as an active ingredient.

    摘要翻译: 包含通过(i)1,4-二羟基-2-萘甲酸的制造方法得到的包含1,4-二羟基-2-萘甲酸的组合物的食品和饮料,其包括引发1,4-二羟基-2-萘甲酸的培养, 或二氧基-2-萘甲酸生产菌,在厌氧条件下属于丙酸菌,并且当培养基中碳源的浓度为3.5质量%以下时,通气培养细菌培养至培养基中,或(ii) 制备1,4-二羟基-2-萘甲酸,包括在厌氧条件下培养属于丙酸细菌的1,4-二羟基-2-萘酸生产菌,向获得的培养物中加入碳源,并在3℃保存培养物 在弱碱性条件下为20℃,或(iii)生产1,4-二羟基-2-萘酸的方法,包括引发属于丙酸菌的1,4-二羟基-2-萘酸生产细菌的培养物 全日空 有氧条件下,培养基中的碳源浓度为3.5质量%以下时,通入培养细菌至培养基中,向得到的培养物中加入碳源,在弱碱性条件下在3〜20℃保存培养基 条件,作为活性成分。

    CHYMOSIN FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS
    7.
    发明公开
    CHYMOSIN FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS 审中-公开
    凝乳酶预防和胃肠道疾病的药物

    公开(公告)号:EP2101810A2

    公开(公告)日:2009-09-23

    申请号:EP07872839.1

    申请日:2007-11-29

    申请人: OU Nutrichym

    摘要: The present invention is directed to medical or dietary treatments comprising administration of a zymogen such as chymosin or other rennins. Embodiments of the invention are directed to treating infant colic, heartburn, gastro-esophageal reflux (GER), gastro-esophageal reflux disease (GERD), irritable bowel syndrome, and recurrent abdominal pain. The invention is also directed to improving absorption of calcium from milk for osteoporosis patients. Further the present invention may have a very positive effect on life quality for groups with different chronic digestion problems such as ulcerous colitis, multiple sclerosis, migraines, weight disorders and diabetes. Infants may be given several drops of a composition containing chymosin prior to every feeding, regardless of whether they are bottle or breast-fed. The composition containing chymosin can also be incorporated into a food product such as drinking milk or baby formula. The rennin helps infants break down milk proteins so that the milk can be transformed into cheese pulp in the stomach, mimicking the process occurring in the stomachs of normal infants.